Skip to main content
Log in

Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Two patients with cysticercosis received praziquantel (PZQ) 75 mg/kg/day orally together with 30 mg prednisone daily for 3 weeks. The first patient presented with grand-mal seizures, a pyramidal tract syndrome and subcutaneous cysticerci, and the other had internal hydrocephalus necessitating drainage. Serial plasma samples were taken after the first dose of PZQ. Lumbar CSF was obtained from the first patient and ventricular CSF from the second. Subcutaneous cysticerci were removed from the first patient. PZQ in the specimens was assayed by GLC.

For distribution between plasma and CSF a rate constant of 4.9 h−1 for free PZQ, corresponding to a t1/2 of 8 min or less for the non-protein bound fraction was calculated for Patient 1. In the second patient the distribution was so rapid that the rate constant could not be calculated. The difference in distribution rate might have been due to use of different sampling times or to a time lag in the entry of PZQ between the ventricles and the lumbar sac.

The rate constant for distribution of the drug between plasma and parasites was 1.4 h−1, corresponding to a t1/2 of 30 min or less. Thus PZQ penetrates rapidly into the CSF. It enters the parasite more slowly, although still more rapidly than the plasma half-life of PZQ (1–1 1/2 h).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Mahajan RC (1982) Geographical distribution of human cysticercosis. In: Flisser A, Willms K, Laclette JP, Larralde C, Ridaura C, and Beltrán F (eds) Cysticercosis: Present state of knowledge and perspectives. Academic Press, New York, pp 39–46

    Google Scholar 

  2. Dixon HBF, Lipscomb FM (1961) Cysticercosis: An analysis and follow-up of 450 cases. Medical Research Special Report Series no. 299. London, H. M. S. O.

    Google Scholar 

  3. Loo L, Braude A (1982) Cerebral cysticercosis in San Diego. A report of 23 cases and a review of the literature. Medicine (Balt) 61: 341–359

    Google Scholar 

  4. McCormick GF, Zee CS, Heiden J (1982) Cysticercosis cerebri. Review of 127 cases. Arch Neurol 39: 534–539

    Google Scholar 

  5. Seubert J, Pohlke R, Loebich F (1977) Synthesis and properties of praziquantel, a novel broad spectrum anthelminic with excellent activity against schistosomes and cestodes. Experientia 33: 1036

    Google Scholar 

  6. Groll E (1981) Cysticercosis human y praziquantel: Una apreciacion panorámica de los primeros experiencias clínicas. Bol Chil Parasitol 36: 29–37

    Google Scholar 

  7. Botero D, Castano S (1982) Treatment of cysticercosis with praziquantel in Columbia. Am J Trop Med Hyg 31: 810–821

    Google Scholar 

  8. De Ghetaldi LD, Norman RM, Douville AW Jr (1983) Cerebral cysticercosis treated biphasically with dexamethazone and praziquantel. Ann Intern Med 99: 179–181

    Google Scholar 

  9. Pearson RD, Guerrant RL (1983) Praziquantel: A major advance in anthelminthic therapy. Ann Intern Med 99: 195–198

    Google Scholar 

  10. Markwalder K, Hess K, Valavanis A, Witassek F (1981) Cerebral cysticercosis: Treatment with praziquantel. Am J Trop Med Hyg 33: 273–289

    Google Scholar 

  11. Sotelo J, Escobedo F, Rodriguez-Carbajal J, Torres B, Rubio-Donnadieu F (1984) Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med 310: 1001–1007

    Google Scholar 

  12. Leopold G, Ungethüm W, Groll E, Diekmann HW, Nowak H, Wegner DHG (1978) Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. Eur J Clin Pharmacol 14: 281–291

    Google Scholar 

  13. Watt G, Long GW, Ranoa CP, Adapon B, Fernando MT, Cross JH (1986) Praziquantel in treatment of cerebral schistosomiasis. Lancet 529–532

  14. Diekmann HW (1979) Quantitative determination of praziquantel in body fluids by gas liquid chromatography. Eur J Drug Metab Pharmacokinet 3: 139–141

    Google Scholar 

  15. Kunst MW, Mattie H (1978) Cefazolin and cephradine: Relationship between serum concentrations and tissue contents in mice. Infection 6: 166–170

    Google Scholar 

  16. Mattie H, Hoogeterp JJ, Hermans J (1987) The relation between plasma and tissue concentrations of antibiotics. Description of a method. J Pharmacokinet Biopharm 15: 191–202

    Google Scholar 

  17. Armitage P (1971) Statistical methods in medical research. Blackwell, Oxford London Edinburgh Melbourne, pp 308–320

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Overbosch, D., van de Nes, J.C.M., Groll, E. et al. Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis. Eur J Clin Pharmacol 33, 287–292 (1987). https://doi.org/10.1007/BF00637564

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00637564

Key words

Navigation